Marianne Lucas-Hourani

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, Institut Curie. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Lucas-Hourani. Retrieved from https://idiyas.com/inventor/marianne-lucas-hourani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 40.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

5 out of 5,383

Centre National De La Recherche Scientifique

where one patent can have more than one assignee

Years Active: 2012-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10227385 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2019-03-12),

2. 9579375 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2017-02-28),

3. 9315482 - Derivatives useful as antiviral agents (2016-04-19),

4. 8853379 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2014-10-07),

5. 8337857 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2012-12-25),

Title: The Innovative Contributions of Marianne Lucas-Hourani

Introduction

Marianne Lucas-Hourani is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions against viral infections. With a total of 5 patents to her name, her work has garnered attention in both academic and industrial circles.

Latest Patents

One of her latest patents is titled "Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection." This invention focuses on the creation of a chimeric polypeptide that can be utilized for the prevention or treatment of Flaviviridae infections. Additionally, the patent discusses the use of this innovative chimeric polypeptide in the production of recombinant viral vectors, such as a measles living viral vector. This groundbreaking work has the potential to impact the way viral infections are treated.

Career Highlights

Throughout her career, Marianne has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of her notable coworkers include Frederic Tangy and Erika Navarro-Sanchez. Their collaborative efforts have further enhanced the impact of her research and innovations.

Conclusion

Marianne Lucas-Hourani's contributions to biotechnology and her innovative patents demonstrate her commitment to advancing medical science. Her work continues to inspire future research and development in the field of viral therapeutics.

Profile summary based on public USPTO records.